A chaotic sprint to lower insulin prices

It’s just days before the Senate is supposed to leave town for summer break, and they’re still engaged in a last-minute scramble to streamline their ambitious plan to lower drug prices. The biggest outstanding issue is insulin. Democrats have pivoted from their plans to pursue insulin pricing policy in a purely bipartisan way, and are instead engaged in a last-second effort to jam as much policy in their reconciliation bill as they can.